4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001753159-25-000006
Co-Chief Executive Officer sold 100,000 shares at an average $105.05 ($10,505,474)
- Co-Chief Executive Officer disposed of 387,946 shares (other)
- Co-Chief Executive Officer acquired 387,946 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Other disposition | −387,946 | 82,854 | I | ||
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Other acquisition | +193,973 | 218,223 | I | ||
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Other acquisition | +193,973 | 218,223 | I | ||
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Sale | −15,000 | $104.21 | $1,563,125 | 203,223 | I |
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Sale | −30,760 | $105.34 | $3,240,172 | 172,463 | I |
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Sale | −4,240 | $106.00 | $449,440 | 168,223 | I |
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Sale | −15,000 | $104.21 | $1,563,125 | 203,223 | I |
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Sale | −30,760 | $105.34 | $3,240,172 | 172,463 | I |
| Talasaz AmirAli Co-Chief Executive Officer | 2025-12-08 | Sale | −4,240 | $106.00 | $449,440 | 168,223 | I |
| Open-market sales · 100,000 sh · avg $105.05 · $10,505,474 | |||||||
Loading xslF345X05/wk-form4_1765420401.xml…